These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1168851)

  • 1. A simple nonradioisotope technic for the determination of platelet life-span.
    Stuart MJ; Murphy S; Oski FA
    N Engl J Med; 1975 Jun; 292(25):1310-3. PubMed ID: 1168851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Platelet-function tests: predictive value.
    Pevine PL
    N Engl J Med; 1975 Jun; 292(25):1346-7. PubMed ID: 1168852
    [No Abstract]   [Full Text] [Related]  

  • 3. Arterial thrombosis associated with immune thrombocytopenia: presence of a platelet aggregating IgG synergistic with thrombin and adrenalin.
    Jackson SP; Jane SM; Mitchell CA; Fernando Cortizo W; Hau L; Pfueller SL; Salem HH
    Thromb Haemost; 1989 Nov; 62(3):846-9. PubMed ID: 2595658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet kinetics with indium-111 platelets: comparison with chromium-51 platelets.
    Peters AM; Lavender JP
    Semin Thromb Hemost; 1983 Apr; 9(2):100-14. PubMed ID: 6346489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet heterogeneity. Relationship between buoyant density, size, lipid peroxidation and platelet age.
    Leone G; Agostini A; DeCrescenzo A; Bizzi B
    Scand J Haematol; 1979 Sep; 23(3):204-10. PubMed ID: 504968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uses and limitations of platelet survival time measurements. A critical assay].
    Baldini MG; Myers TJ
    Haematologica; 1980 Dec; 65(6):689-716. PubMed ID: 6790361
    [No Abstract]   [Full Text] [Related]  

  • 8. [The study of platelet kinetics with 51Cr labeled platelets (author's transl)].
    Rosenblit MD
    Rev Bras Pesqui Med Biol; 1976; 9(1):45-53. PubMed ID: 945594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
    Huzoor-Akbar ; Ardlie NG
    Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody.
    Okuma M; Steiner M; Baldini G
    J Lab Clin Med; 1971 May; 77(5):728-42. PubMed ID: 5557659
    [No Abstract]   [Full Text] [Related]  

  • 12. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study].
    Yoshii K; Seki Y; Aiba T; Tsukada T; Shiozawa R
    No To Shinkei; 1985 Oct; 37(10):985-90. PubMed ID: 4074576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
    Zisman E; Erport A; Kohanovsky E; Ballagulah M; Cassel A; Quitt M; Pizov R
    Eur J Anaesthesiol; 2010 Jul; 27(7):617-23. PubMed ID: 20035230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of factor VIII concentrate on malondialdehyde release by normal human platelets].
    Geroldi D; Cervini L
    Boll Soc Ital Biol Sper; 1979 Apr; 55(7):675-81. PubMed ID: 121702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.